Table 5.
Factors |
DFS |
OS |
||||
HR | 95%CI | P | HR | 95%CI | P | |
Age | 1.028 | 0.825-1.770 | 0.331 | 0.932 | 0.667-1.303 | 0.682 |
Gender | 1.072 | 0.634-1.814 | 0.795 | 0.791 | 0.543-1.151 | 0.220 |
Tumor size | 1.718 | 1.159-2.546 | 0.007 | 1.998 | 1.433-2.785 | < 0.001 |
Differentiation | 1.398 | 0.685-2.853 | 0.357 | 0.714 | 0.398-1.281 | 0.258 |
T category | 0.796 | 0.213-2.978 | 0.734 | 6.042 | 2.190-16.668 | 0.001 |
N category | 1.014 | 0.836-1.231 | 0.884 | 1.734 | 1.429-2.014 | < 0.001 |
Vascular/nerves invasion | 0.930 | 0.606-1.426 | 0.739 | 1.515 | 1.045-2.195 | 0.028 |
Adjuvant chemotherapy | 0.931 | 0.614-1.411 | 0.736 | 0.618 | 0.425-0.898 | 0.012 |
CEA | 3.045 | 0.401-23.157 | 0.282 | 0.902 | 0.618-1.316 | 0.592 |
CA19-9 | 0.392 | 0.045-3.384 | 0.394 | 0.836 | 0.449-1.556 | 0.571 |
CA50 | 1.058 | 0.546-2.050 | 0.868 | 1.470 | 0.842-2.569 | 0.176 |
CEA: Carcinoembryonic antigen; CA: Carbohydrate antigen; DFS: Disease-free survival; OS: Overall survival.